ATE278420T1 - Monophosphoryllipid a enthaltende adjuvans- und impfstoffzusammensetzungen - Google Patents

Monophosphoryllipid a enthaltende adjuvans- und impfstoffzusammensetzungen

Info

Publication number
ATE278420T1
ATE278420T1 AT99935566T AT99935566T ATE278420T1 AT E278420 T1 ATE278420 T1 AT E278420T1 AT 99935566 T AT99935566 T AT 99935566T AT 99935566 T AT99935566 T AT 99935566T AT E278420 T1 ATE278420 T1 AT E278420T1
Authority
AT
Austria
Prior art keywords
adjuvant
vaccine compositions
monophosphoryllipide
compositions containing
reform
Prior art date
Application number
AT99935566T
Other languages
English (en)
Inventor
Vincent James Laposta
John Hayward Eldridge
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE278420T1 publication Critical patent/ATE278420T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT99935566T 1998-07-14 1999-07-13 Monophosphoryllipid a enthaltende adjuvans- und impfstoffzusammensetzungen ATE278420T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11539298A 1998-07-14 1998-07-14
PCT/US1999/015942 WO2000003744A2 (en) 1998-07-14 1999-07-13 Adjuvant and vaccine compositions containing monophosphoryl lipid a

Publications (1)

Publication Number Publication Date
ATE278420T1 true ATE278420T1 (de) 2004-10-15

Family

ID=22361090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99935566T ATE278420T1 (de) 1998-07-14 1999-07-13 Monophosphoryllipid a enthaltende adjuvans- und impfstoffzusammensetzungen

Country Status (14)

Country Link
EP (1) EP1096954B1 (de)
JP (1) JP2002520373A (de)
KR (1) KR100586804B1 (de)
CN (1) CN1247262C (de)
AT (1) ATE278420T1 (de)
AU (1) AU763770B2 (de)
BR (1) BR9912067A (de)
CA (1) CA2333578C (de)
DE (1) DE69920915T2 (de)
DK (1) DK1096954T3 (de)
ES (1) ES2229745T3 (de)
IL (1) IL140890A0 (de)
PT (1) PT1096954E (de)
WO (1) WO2000003744A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
AP1502A (en) 1998-12-22 2005-12-20 Microscience Ltd Genes and proteins, and their uses.
JP5004261B2 (ja) * 2000-05-19 2012-08-22 コリクサ コーポレイション 単糖類及び二糖類に基づく化合物を用いた感染症及び他の疾患の予防的並びに治療的な処置
FR2814956B1 (fr) * 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
BRPI0614254A2 (pt) * 2005-08-02 2011-03-15 Novartis Vaccines & Diagnostic redução de interferência entre adjuvantes contendo óleo e antìgenos contendo tensoativos
JP6109165B2 (ja) * 2011-07-01 2017-04-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ヘルペスウイルスワクチンおよび使用方法
US9241988B2 (en) 2012-04-12 2016-01-26 Avanti Polar Lipids, Inc. Disaccharide synthetic lipid compounds and uses thereof
US20160193326A1 (en) * 2013-09-05 2016-07-07 Immune Design Corp. Vaccine Compositions for Drug Addiction
WO2023212702A2 (en) * 2022-04-28 2023-11-02 Kansas State University Research Foundation Corralling amphipathic peptide colloids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672496B3 (fr) * 1990-07-18 1993-05-28 Vacsyn France Sa Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.
EP1175912A1 (de) * 1993-03-23 2002-01-30 SmithKline Beecham Biologics SA 3-0-deazylierte Monophosphoryl Lipid A enthaltende Impfstoff-Zusammensetzungen
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
GB9612137D0 (en) * 1996-06-10 1996-08-14 Quaker Oats Co Treatment of dried fruit
US6235724B1 (en) * 1996-07-03 2001-05-22 Eisai Co., Ltd. Injections containing lipid a analogues and process for the preparation thereof

Also Published As

Publication number Publication date
DE69920915D1 (de) 2004-11-11
CN1307483A (zh) 2001-08-08
JP2002520373A (ja) 2002-07-09
EP1096954B1 (de) 2004-10-06
DE69920915T2 (de) 2006-02-16
CA2333578C (en) 2010-11-16
AU5101899A (en) 2000-02-07
CA2333578A1 (en) 2000-01-27
BR9912067A (pt) 2001-04-10
WO2000003744A2 (en) 2000-01-27
EP1096954A2 (de) 2001-05-09
KR20010071637A (ko) 2001-07-28
CN1247262C (zh) 2006-03-29
KR100586804B1 (ko) 2006-06-07
WO2000003744A3 (en) 2000-04-27
ES2229745T3 (es) 2005-04-16
IL140890A0 (en) 2002-02-10
DK1096954T3 (da) 2005-01-31
AU763770B2 (en) 2003-07-31
PT1096954E (pt) 2004-12-31

Similar Documents

Publication Publication Date Title
IS5329A (is) Flutningskerfi fyrir antígen þar sem monoglýseríðeða díglýseríð afleiður eru ónæmisglæðar
WO2003039330A3 (en) Devices and methods to correct spinal deformities
WO1999040936A3 (en) Pneumococcal and meningococcal vaccines formulated with interleukin-12
NZ513202A (en) Antigen composition comprising Bordetella bronchiseptica, formalin and glutaraldehyde
EP1076566A4 (de) Attenuierte salmonellamutanten, welche das vi-antigen konstant exprimieren
IL140710A0 (en) Pulmonary delivery of active agents
ATE238415T1 (de) Feste phytase-zusammensetzungen
NO20002741L (no) Vaksine-blandinger omfattende kitosan, for mukosal administrasjon
PT1163008E (pt) Utilizacao de trealose para estabilizacao de uma vacina liquida
DE69920915D1 (de) Monophosphoryllipid a enthaltende adjuvans- und impfstoffzusammensetzungen
DE69524742D1 (de) Interleukin-11 präparat
JO2386B1 (en) Dispersing compounds containing lipase inhibitors
BR0011030A (pt) Composições de cicloporina substancialmente livre de óleo
WO2003059916A8 (en) Methods for the preparation of alkyl diaryl borinates and complexed diarylborinic acids
BG103914A (en) Maintained separation of delayed gels
DE69634024D1 (de) Adjuvans für vitale Impfstoffe
CA2177667A1 (en) Mammalian vaccine compositions comprising squalene or squalane, lecithin and a polyoxyethylene sorbitan ester as an adjuvant
DK1053017T3 (da) Vacciner omfattende interleukin-12 og herpes simplex virusantigen
MXPA01003501A (es) Metodo para moderar el estres o tension de las plantas.
WO2000033887A3 (en) Methods and formulations for reducing circulating antibodies
AU2001258373A1 (en) Method for identifying helicobacter antigens
WO2002017858A3 (en) Role of fosb in bone formation
CA2442698A1 (en) Thermolabile liposome with controlled release temperature
AR016514A1 (es) Composicion para mejorar el malestar estomacal, metodo para preparar dicha composicion y metodo para utilizarla
MXPA05009447A (es) Vacunas bovinas con adyuvante.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1096954

Country of ref document: EP

REN Ceased due to non-payment of the annual fee